chr7-107660799-A-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 2P and 3B. PM2BP4_ModerateBP6
The NR_028137.1(SLC26A4-AS1):n.198-593T>C variant causes a intron, non coding transcript change. The variant allele was found at a frequency of 0.000309 in 152,272 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.00031 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
SLC26A4-AS1
NR_028137.1 intron, non_coding_transcript
NR_028137.1 intron, non_coding_transcript
Scores
2
Clinical Significance
Conservation
PhyloP100: 4.40
Genes affected
SLC26A4-AS1 (HGNC:22385): (SLC26A4 antisense RNA 1)
SLC26A4 (HGNC:8818): (solute carrier family 26 member 4) Mutations in this gene are associated with Pendred syndrome, the most common form of syndromic deafness, an autosomal-recessive disease. It is highly homologous to the SLC26A3 gene; they have similar genomic structures and this gene is located 3' of the SLC26A3 gene. The encoded protein has homology to sulfate transporters. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -1 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.31).
BP6
Variant 7-107660799-A-G is Benign according to our data. Variant chr7-107660799-A-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 666917.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=1, Uncertain_significance=2}.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC26A4-AS1 | NR_028137.1 | n.198-593T>C | intron_variant, non_coding_transcript_variant | |||||
SLC26A4 | NM_000441.2 | upstream_gene_variant | ENST00000644269.2 | NP_000432.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC26A4-AS1 | ENST00000668981.1 | n.257+803T>C | intron_variant, non_coding_transcript_variant | |||||||
SLC26A4 | ENST00000644269.2 | upstream_gene_variant | NM_000441.2 | ENSP00000494017 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000309 AC: 47AN: 152154Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
47
AN:
152154
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome Data not reliable, filtered out with message: AC0;AS_VQSR AF: 0.00 AC: 0AN: 50Hom.: 0 Cov.: 0 AF XY: 0.00 AC XY: 0AN XY: 42
GnomAD4 exome
Data not reliable, filtered out with message: AC0;AS_VQSR
AF:
AC:
0
AN:
50
Hom.:
Cov.:
0
AF XY:
AC XY:
0
AN XY:
42
Gnomad4 AFR exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 NFE exome
AF:
GnomAD4 genome AF: 0.000309 AC: 47AN: 152272Hom.: 0 Cov.: 32 AF XY: 0.000349 AC XY: 26AN XY: 74454
GnomAD4 genome
AF:
AC:
47
AN:
152272
Hom.:
Cov.:
32
AF XY:
AC XY:
26
AN XY:
74454
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Dec 19, 2018 | The c.-60A>G variant in SLC26A4 has been previously reported in 1 individual wit h unilateral enlarged vestibular aqueduct (Choi 2009), but has also been identif ied in 0.15% (13/8710) of African chromosomes by gnomAD (http://gnomad.broadinst itute.org). This variant is in the 5' untranslated region and the impact, if any , on the protein is unknown. In summary, the clinical significance of this varia nt is uncertain. ACMG/AMP criteria: BS1_Supporting. - |
SLC26A4-related disorder Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 15, 2023 | The SLC26A4 c.-60A>G variant is located in the 5' untranslated region. This variant was reported in an individual with hearing loss due to an enlarged vestibular aqueduct (Choi et al 2009. PubMed ID: 19204907). This variant is reported in 0.15% of alleles in individuals of African descent in gnomAD (http://gnomad.broadinstitute.org/variant/7-107301244-A-G). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 08, 2023 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at